Tag Archives: public policy

Now What is Patentable?

lab_tech

On Tuesday of the Pacific Rim Summit, experts from Knobbe Martens, BIO, and Synthetic Genomics explored the legal, policy and business implications of the Myriad decision, the United States Patent and Trademark Office (PTO) guidance on patentable subject matter under Myriad issued earlier this year, and the revised Myriad guidance expected from the PTO later this year. The Patent Copyright Clause, United States Constitution, Article 1, Section 8: To promote the progress of science and useful arts, by Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Indian Patents Ensure Wide Access to Drugs, Without Raising Prices

patent

Two recent studies on Indian drugs have shown that patent protection does not dramatically increase prices, but does ensure widespread access to life saving therapeutics. This research confirms that a weak patent environment slows drug availability and hinders treatment to many people in need. Data Shows Little Change in Indian Drug Prices after Implementing Stronger Patent System In a new report published by the National Bureau of Economic Research, scholars found that patented drugs did not Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Milwaukee Journal Sentinel Story on Use of Surrogate Measures

lab_tech

Earlier this week, John Fauber of the Milwaukee Journal Sentinel wrote an article on measures used to determine whether new medicines for serious and life-threatening diseases should reach patients. Fauber seem(s) to suggest that the use of surrogate measures – such as tumor shrinkage – do not provide evidence of drug efficacy. The story fails to present a balanced view of the complex benefit-risk assessments that the FDA must carefully consider when reviewing applications for Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

Patent Cases Down by 40% in 2014

Patent-Case-Filings-by-Month-2011-20141

The number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. This trend has some questioning whether Congressional patent reform is even necessary. Some legal experts are attributing this drop to the fallout from the U.S. Supreme Court’s recent Alice vs. CLS Bank decision. In June, SCOTUS ruled in the case of Alice that certain subject matter which had been patentable (a computer-implemented Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , ,

Center for Medicine in the Public Interest Challenges Accuracy of 60 Minutes Cancer Story

scientist-eyedropper

This week, the Center for Medicine in the Public Interest issued a press release criticizing CBS’ “60 Minutes” segment on cancer treatment prices as not just distorted but ‘dead wrong.’ “Featuring physicians that argue that treatment prices are too high does not change the fact that the cost of cancer drugs are about 12 percent of what health insurers spend on cancer or that new cancer drugs actually save health insurers money. Yet insurers are Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,